These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 26280213

  • 1. Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia.
    Zang Z, Li S, Zhang W, Chen X, Zheng D, Shu H, Guo W, Zhao B, Shen K, Wei Y, Zheng X, Liu S, Yang H.
    J Mol Neurosci; 2015 Oct; 57(2):265-72. PubMed ID: 26280213
    [Abstract] [Full Text] [Related]

  • 2. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S, Zang Z, He J, Chen X, Yu S, Pei Y, Hou Z, An N, Yang H, Zhang C, Liu S.
    Oncotarget; 2017 Jan 24; 8(4):6883-6895. PubMed ID: 28036289
    [Abstract] [Full Text] [Related]

  • 3. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
    Wang LK, Chen X, Zhang CQ, Liang C, Wei YJ, Yue J, Liu SY, Yang H.
    J Mol Neurosci; 2017 Jun 24; 62(2):222-231. PubMed ID: 28455787
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of TRPC5 in cortical lesions of the focal cortical dysplasia.
    Xu GZ, Shu HF, Yue HY, Zheng DH, Guo W, Yang H.
    J Mol Neurosci; 2015 Mar 24; 55(3):561-9. PubMed ID: 25085710
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of fibroblast growth factor 13 in cortical lesions of the focal cortical dysplasia.
    Wu K, Yue J, Shen K, He J, Zhu G, Liu S, Zhang C, Yang H.
    Brain Res Bull; 2021 Mar 24; 168():36-44. PubMed ID: 33285262
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 24; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 8. Expression of TRPC3 in cortical lesions from patients with focal cortical dysplasia.
    Liang C, Chen X, Zhang CQ, An N, Liu SY, Zheng DH, Yang H.
    Neurosci Lett; 2020 Apr 17; 724():134880. PubMed ID: 32135163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L, Villani F, Granata T, Tassi L, Tringali G, Cardinale F, Aronica E, Spreafico R, Garbelli R.
    Epilepsy Res; 2017 Jan 17; 129():146-156. PubMed ID: 28056425
    [Abstract] [Full Text] [Related]

  • 11. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb.
    Yu S, Li S, Shu H, Zhang C, He J, Fan X, Yang H.
    Neuroreport; 2012 May 09; 23(7):407-11. PubMed ID: 22494998
    [Abstract] [Full Text] [Related]

  • 12. Complex Patterns of GABAergic Neuronal Deficiency and Type 2 Potassium-Chloride Cotransporter Immaturity in Human Focal Cortical Dysplasia.
    Han P, Welsh CT, Smith MT, Schmidt RE, Carroll SL.
    J Neuropathol Exp Neurol; 2019 Apr 01; 78(4):365-372. PubMed ID: 30856249
    [Abstract] [Full Text] [Related]

  • 13. The interleukin 17 system in cortical lesions in focal cortical dysplasias.
    He JJ, Li S, Shu HF, Yu SX, Liu SY, Yin Q, Yang H.
    J Neuropathol Exp Neurol; 2013 Feb 01; 72(2):152-63. PubMed ID: 23334598
    [Abstract] [Full Text] [Related]

  • 14. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun 01; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
    Zhang Z, Liu Q, Liu M, Wang H, Dong Y, Ji T, Liu X, Jiang Y, Cai L, Wu Y.
    J Neuroinflammation; 2018 Jan 30; 15(1):27. PubMed ID: 29382328
    [Abstract] [Full Text] [Related]

  • 16. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
    Mao C, Jin L, Dou W, Lu Q, Zhou L, Ren H, Zhao Y, Feng F, Guo Y, Gao J.
    Epilepsy Res; 2019 Nov 30; 157():106189. PubMed ID: 31472401
    [Abstract] [Full Text] [Related]

  • 17. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar 30; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 18. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS, Baldassari S, Stephenson SEM, Lockhart PJ, Baulac S, Leventer RJ.
    Int J Mol Sci; 2022 Jan 25; 23(3):. PubMed ID: 35163267
    [Abstract] [Full Text] [Related]

  • 19. Increased Expression of Transient Receptor Potential Vanilloid 4 in Cortical Lesions of Patients with Focal Cortical Dysplasia.
    Chen X, Sun FJ, Wei YJ, Wang LK, Zang ZL, Chen B, Li S, Liu SY, Yang H.
    CNS Neurosci Ther; 2016 Apr 25; 22(4):280-90. PubMed ID: 26842013
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ.
    Histol Histopathol; 2024 Sep 25; 39(9):1179-1195. PubMed ID: 38293776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.